The Doha Declaration on the TRIPS Agreement and Public Health recognized that developing countries with insufficient, or no manufacturing capacity in the pharmaceutical sector could face difficulties in making effective use of compulsory licensing under the TRIPS Agreement. The World Health Organization's (WTO) decision of August 30, 2003 set up a system intended to overcome these difficulties. The present work is a guide to the implementation of...
更多显示
详细
-
2005/07/01
-
出版
-
33426
-
1
-
1
-
2010/07/01
-
Disclosed
-
Compulsory licensing for public health - a guide and model documents for implementation of the Doha Declaration Paragraph 6 Decision
-
trips agreement